171 related articles for article (PubMed ID: 21893222)
1. Zinc deficiency decreases osteoblasts and osteoclasts associated with the reduced expression of Runx2 and RANK.
Hie M; Iitsuka N; Otsuka T; Nakanishi A; Tsukamoto I
Bone; 2011 Dec; 49(6):1152-9. PubMed ID: 21893222
[TBL] [Abstract][Full Text] [Related]
2. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone.
Hie M; Tsukamoto I
Eur J Pharmacol; 2011 Oct; 668(1-2):140-6. PubMed ID: 21806983
[TBL] [Abstract][Full Text] [Related]
3. Zinc supplementation inhibits the increase in osteoclastogenesis and decrease in osteoblastogenesis in streptozotocin-induced diabetic rats.
Iitsuka N; Hie M; Tsukamoto I
Eur J Pharmacol; 2013 Aug; 714(1-3):41-7. PubMed ID: 23735664
[TBL] [Abstract][Full Text] [Related]
4. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation.
Hie M; Iitsuka N; Otsuka T; Tsukamoto I
Int J Mol Med; 2011 Sep; 28(3):455-62. PubMed ID: 21567076
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes.
Hie M; Tsukamoto I
Int J Mol Med; 2010 Oct; 26(4):611-8. PubMed ID: 20818503
[TBL] [Abstract][Full Text] [Related]
6. Ethanol increases osteoclastogenesis associated with the increased expression of RANK, PU.1 and MITF in vitro and in vivo.
Iitsuka N; Hie M; Nakanishi A; Tsukamoto I
Int J Mol Med; 2012 Jul; 30(1):165-72. PubMed ID: 22576626
[TBL] [Abstract][Full Text] [Related]
7. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
[TBL] [Abstract][Full Text] [Related]
8. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
9. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
[TBL] [Abstract][Full Text] [Related]
10. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
11. Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro.
Karieb S; Fox SW
Br J Nutr; 2012 Nov; 108(10):1736-45. PubMed ID: 22289672
[TBL] [Abstract][Full Text] [Related]
12. Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells.
Notoya M; Otsuka E; Yamaguchi A; Hagiwara H
Biochem Biophys Res Commun; 2004 Nov; 324(2):655-60. PubMed ID: 15474477
[TBL] [Abstract][Full Text] [Related]
13. Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression.
Hie M; Tsukamoto I
J Nutr Biochem; 2011 Feb; 22(2):164-71. PubMed ID: 20444587
[TBL] [Abstract][Full Text] [Related]
14. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
[TBL] [Abstract][Full Text] [Related]
15. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.
Kim HJ; Minashima T; McCarthy EF; Winkles JA; Kirsch T
J Bone Miner Res; 2010 Aug; 25(8):1771-83. PubMed ID: 20200976
[TBL] [Abstract][Full Text] [Related]
16. Fish oil suppresses bone resorption by inhibiting osteoclastogenesis through decreased expression of M-CSF, PU.1, MITF and RANK in ovariectomized rats.
Nakanishi A; Iitsuka N; Tsukamoto I
Mol Med Rep; 2013 Jun; 7(6):1896-903. PubMed ID: 23625116
[TBL] [Abstract][Full Text] [Related]
17. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
18. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
Evans CE; Mylchreest S; Andrew JG
BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
[TBL] [Abstract][Full Text] [Related]
19. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms.
Granholm S; Lundberg P; Lerner UH
J Endocrinol; 2007 Dec; 195(3):415-27. PubMed ID: 18000304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
